Modulating gut microbiota as an anti-diabetic mechanism of berberine. (Q36516516)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

review article

4 references

27 October 2020

4 February 2021

19 July 2022

Modulating gut microbiota as an anti-diabetic mechanism of berberine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

8 references

13 March 2019

14 March 2019

19 March 2019

24 March 2019

8 September 2019

7 October 2019

18 November 2019

27 October 2020

5 references

8 September 2019

7 October 2019

18 November 2019

27 October 2020

4 February 2021

regulation of gene expression

1 reference

PubMed

8 September 2019

human digestive system

1 reference

7 October 2019

1 reference

18 November 2019

anti-diabetic medication

1 reference

27 October 2020

Junling Han

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Huiling Lin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Weiping Huang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 July 2011

11 references

13 March 2019

14 March 2019

19 March 2019

24 March 2019

8 September 2019

7 October 2019

18 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

27 October 2020

4 February 2021

19 July 2022

Medical Science Monitor

11 references

13 March 2019

14 March 2019

19 March 2019

24 March 2019

8 September 2019

7 October 2019

18 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

27 October 2020

4 February 2021

19 July 2022

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

RA164-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

6 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Antioxidant therapy in human endocrine disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

The role of the gut microbiota in energy metabolism and metabolic disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Efficacy of berberine in patients with type 2 diabetes mellitus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Berberine improves glucose metabolism through induction of glycolysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

An obesity-associated gut microbiome with increased capacity for energy harvest

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Microbial ecology: human gut microbes associated with obesity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Inflammation and metabolic disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Obesity alters gut microbial ecology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

The indigenous gastrointestinal microflora

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Berberine targets assembly of Escherichia coli cell division protein FtsZ.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

Berberine inhibits arylamine N-acetyltransferase activity and gene expression in Salmonella typhi

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539561

21 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21709646

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21709646

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.12659/MSM.881842

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709646%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

21709646

1 reference